Concurrent carboplatin and paclitaxel with pelvic radiation therapy in the primary treatment of cervical cancer

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 2, 2007, Pages 205.e1-205.e7

  Higgins, Robert ^a   Bussey, Mary ^a   Naumann, Wendel ^a   Hall, James ^a   Tait, David ^a   Haake, Michael ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

carboplatin; cervical cancer; paclitaxel; radiation therapy; toxicities

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; DEHYDRATION; DIARRHEA; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; FEASIBILITY STUDY; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; NEPHROTOXICITY; NEUROTOXICITY; PELVIS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

EID: 34547579514     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.04.047     Document Type: Article

References (26)

1. Benedet J., Odicino F., Maisonneuve P., et al. FIGO 90-92 annual report. J Epidemiol Biostat 3 (1998) 1-34
2. Coia L., Won M., Lanciano R., Marcial V.A., Martz K., and Hanks G. The patterns of care outcome study for cancer of the uterine cervix: results of the second national practice survey. Cancer 66 (1990) 2451-2456
3. Morris M., Eifel P., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
4. Keys H., Bundy B., Stehman F., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
5. Rose P., Bundy B., Watkins E., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
6. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
7. Peters W.A., Liu P., Barrett R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
8. McGuire W.P., Blessing J.A., Moore D.H., Lentz S.S., and Photopulos G. Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol 14 (1996) 792-795
9. Liebman J., Cook J.A., Fisjer J., Teague D., and Mitchell J.B. In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst 86 (1994) 441-446
10. Moore D.H., McQuellon R.P., Blessing J.A., et al. A randomized phase III study of cisplatin versus cisplatin versus cisplatin plus paclitaxel in stage IVB recurrent or persistent squamous cell carcinoma of the cervix. Gynecol Oncol 80 (2001) 276
11. Calvert A.H., Newell D.R., Gumbrell L.A., et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7 (1989) 1748-1756
12. Go R.S., and Adjei A.A. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 17 (1999) 409-422
13. Higgins R.V., Naumann W.R., Hall J.B., and Haake M. Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. Gynecol Oncol 89 (2003) 499-503
14. Choy H., Akerley W., and DeVore III R.F. Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer. Semin Oncol 26 (1999) 36-43
15. Suntharalingam M., Haas M.L., Conley B.A., et al. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 47 (2000) 49-56
16. Rao G.G., Rogers P., Drake R.D., Nguyen P., and Coleman R.L. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Gyn Oncol 96 (2005) 168-172
17. Centia l, Rivera L, Hinojosa J, et al. Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results. Available at: http://www.biomedcentral.com/1472-6874/6/3/prepub. Accessed Jan. 19, 2007
18. Green J., Kirwan J., Tierney J., et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 3 (2005) CD002225
19. Kudelka A.P., Winn R., and Edwards C.L. Activity of paclitaxel in advanced or recurrent squamous-cell cancer of the cervix. Cancer Res 2 (1996) 1285-1288
20. Rose P.G., Blessing J.A., Gershenson D.M., and McGehee R. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 17 (1999) 2676-2680
21. Papadimitriou C., Sarris K., and Moulopoulos L.A. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J Clin Oncol 17 (1999) 761-766
22. Pignata S., Frezza P., Tramontana S., et al. Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri. Ann Oncol 11 (2000) 455-459
23. Petera J., Odrazka K., Frgala T., and Spacek J. External beam radiotherapy and high-dose brachytherapy combined with cisplatin and paclitaxel in patients with advanced cervical carcinoma. Gyn Oncol 99 (2005) 334-338
24. Corn B.W., Micaily B., Dunton C.J., et al. Concomitant irradiation and dose-escalating carboplatin for locally advanced carcinoma of the uterine cervix. An updated report. Am J Clin Oncol 21 (1998) 31-35
25. Duenas-Gonzalez A., Cetina L., Sanchez B., et al. A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma. Int J Radiat Oncol Biol Phys 56 (2003) 1361-1365
26. de Vos F.Y.F.L., Bos A.M.E., Gietema J.A., et al. Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer. Anticancer Res 24 (2004) 345-348